Order Article Reprints

Liu Z, Huang K, Huang H, Kim E, Kim H, Kim CY, Kim DJ, Lee SI, Kim S, Kim DY, et al. Isoquercitrin Suppresses Esophageal Squamous Cell Carcinoma (ESCC) by Inducing Excessive Autophagy and Promoting Apoptosis via the AKT/mTOR Signaling Pathway. Antioxidants. 2025; 14(6):694. https://doi.org/10.3390/antiox14060694

Liu, Zhibin, Ke Huang, Hai Huang, Eungyung Kim, Hyeonjin Kim, Chae Yeon Kim, Dong Joon Kim, Sang In Lee, Sangsik Kim, Do Yoon Kim, and et al. 2025. "Isoquercitrin Suppresses Esophageal Squamous Cell Carcinoma (ESCC) by Inducing Excessive Autophagy and Promoting Apoptosis via the AKT/mTOR Signaling Pathway" Antioxidants 14, no. 6: 694. https://doi.org/10.3390/antiox14060694

Liu, Z., Huang, K., Huang, H., Kim, E., Kim, H., Kim, C. Y., Kim, D. J., Lee, S. I., Kim, S., Kim, D. Y., Liu, K., Ryoo, Z. Y., Lee, M.-H., Ma, L., & Kim, M. O. (2025). Isoquercitrin Suppresses Esophageal Squamous Cell Carcinoma (ESCC) by Inducing Excessive Autophagy and Promoting Apoptosis via the AKT/mTOR Signaling Pathway. Antioxidants, 14(6), 694. https://doi.org/10.3390/antiox14060694